Read more about the current advancements and innovations made towards finding a cure for ALS (Lou Gehrig’s disease)
Our recent work with the Sheffield Institute of Translational Neuroscience (SITraN) on finding treatments for ALS is featured on Reuters UK. BenevolentBio CEO Professor Jackie Hunter and Dr Richard Mead of SITraN are interviewed about the effects of the disease and the process involved in finding the treatments.
We teamed up with Sheffield Institute for Translational Neuroscience (SITraN) to test some of our AI-driven hypotheses in its ALS disease models. Dr Laura Ferraiulo, co-lead on the project from SITraN, spoke to IDG Connect about how this led to a potentially major breakthrough.
Ken Mulvany, is interviewed by Business Insider UK in an article exploring BenevolentAI’s work to develop new drugs for diseases like Alzheimer’s and ALS.